Atlas Trials

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

Clinical trial NCT00580372 · COMPLETED

Trial details

NCT number
NCT00580372
Sponsor
University of Arkansas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2002-08-01
Primary completion
2015-10-01
Enrollment
231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.